Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

por Tai, Yu-Tzu, Cho, Shih-Feng, Anderson, Kenneth C.
Publicado 2018

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

por Cho, Shih-Feng, Anderson, Kenneth C., Tai, Yu-Tzu
Publicado 2018

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

por Wang, Hui-Ching, Chan, Leong-Perng, Cho, Shih-Feng
Publicado 2019

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma

por Cho, Shih-Feng, Xing, Lijie, Anderson, Kenneth C., Tai, Yu-Tzu
Publicado 2021

Bispecific antibodies in multiple myeloma treatment: A journey in progress

por Cho, Shih-Feng, Yeh, Tsung-Jang, Anderson, Kenneth C., Tai, Yu-Tzu
Publicado 2022

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice

por Wang, Hui-Ching, Yeh, Tsung-Jang, Chan, Leong-Perng, Hsu, Chin-Mu, Cho, Shih-Feng
Publicado 2020

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma

por Hsiao, Hui-Hua, Wang, Hui-Ching, Tsai, Yu-Fen, Hsiao, Chien, Cho, Shih-Feng, Liu, Yi-Chang
Publicado 2018

Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

por Cho, Shih-Feng, Lin, Liang, Xing, Lijie, Yu, Tengteng, Wen, Kenneth, Anderson, Kenneth C., Tai, Yu-Tzu
Publicado 2017

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

por Cho, Shih-Feng, Lin, Liang, Xing, Lijie, Li, Yuyin, Yu, Tengteng, Anderson, Kenneth C, Tai, Yu-Tzu
Publicado 2020

Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study

por Cho, Shih-Feng, Wu, Wan-Hsuan, Yang, Yi-Hsin, Liu, Yi-Chang, Hsiao, Hui-Hua, Chang, Chao-Sung
Publicado 2015

Prognostic significance of retention index of bone marrow on dual-phase (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-c...

por Chang, Chin-Chuan, Cho, Shih-Feng, Chuang, Ya-Wen, Lin, Chia-Yang, Huang, Ying-Fong, Tyan, Yu-Chang
Publicado 2018

Prognostic significance of total metabolic tumor volume on (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma...

por Chang, Chin-Chuan, Cho, Shih-Feng, Chuang, Ya-Wen, Lin, Chia-Yang, Chang, Shu-Min, Hsu, Wen-Ling, Huang, Ying-Fong
Publicado 2017

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression

por Cho, Shih-Feng, Chang, Yuli Christine, Chang, Chao-Sung, Lin, Sheng-Fung, Liu, Yi-Chang, Hsiao, Hui-Hua, Chang, Jan-Gowth, Liu, Ta-Chih
Publicado 2014

Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma

por Cho, Shih-Feng, Liu, Yi-Chang, Hsiao, Hui-Hua, Huang, Chiung-Tang, Tsai, Yu-Fen, Wang, Hui-Ching, Lin, Sheng-Fung, Liu, Ta-Chih
Publicado 2017

Tumor and bone marrow uptakes on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receivi...

por Chang, Chin-Chuan, Cho, Shih-Feng, Tu, Hung-Pin, Lin, Chia-Yang, Chuang, Ya-Wen, Chang, Shu-Min, Hsu, Wen-Ling, Huang, Ying-Fong
Publicado 2017

Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan

por Tsai, Yu-Fen, Huang, Wen-Chuan, Cho, Shih-Feng, Hsiao, Hui-Hua, Liu, Yi-Chang, Lin, Sheng-Fung, Liu, Ta-Chih, Chang, Chao-Sung
Publicado 2018

Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a...

por Wang, Hui-Ching, Liu, Pei-Lin, Lo, Pei-Chuan, Chang, Yi-Tzu, Chan, Leong-Perng, Yeh, Tsung-Jang, Hsiao, Hui-Hua, Cho, Shih-Feng
Publicado 2020

Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma

por Wang, Hui-Ching, Hsiao, Hui-Hua, Du, Jeng-Shiun, Cho, Shih-Feng, Yeh, Tsung-Jang, Gau, Yuh-Ching, Liu, Yi-Chang, Moi, Sin-Hua
Publicado 2021

Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study

por Cho, Shih-Feng, Yang, Yi-Hsin, Liu, Yi-Chang, Hsiao, Hui-Hua, Huang, Chiung-Tang, Wu, Cheng-Han, Tsai, Yu-Fen, Wang, Hui-Ching, Liu, Ta-Chih
Publicado 2015

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

por Xing, Lijie, Lin, Liang, Yu, Tengteng, Li, Yuyin, Cho, Shih-Feng, Liu, Jiye, Wen, Kenneth, Hsieh, Phillip A, Kinneer, Krista, Munshi, Nikhil, Anderson, Kenneth C, Tai, Yu-Tzu
Publicado 2020